Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwei Peng

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Oncologist|February 20, 2026
ECOG 6293: Phase II Study of Raltitrexed in Advanced Colorectal CancerChengwei Peng, Paul Catalano, John Zalcberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort StudyChengwei Peng, Saad Saffo, Paul E Oberstein, et al.
Cancer Research Communications|April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade GliomaLucas A Salas, Thomas G Stewart, Bret C Mobley, et al.
Journal for Immunotherapy of Cancer|December 6, 2022
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancerYuanwang Pan, Yuan Hao, Han Han, et al.
Cancer Research|August 12, 2021
Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaAngeliki Karatza, Maayan Pour, Jaylen M Powell, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Oncologist|February 20, 2026
ECOG 6293: Phase II Study of Raltitrexed in Advanced Colorectal CancerChengwei Peng, Paul Catalano, John Zalcberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort StudyChengwei Peng, Saad Saffo, Paul E Oberstein, et al.
Cancer Research Communications|April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade GliomaLucas A Salas, Thomas G Stewart, Bret C Mobley, et al.
Journal for Immunotherapy of Cancer|December 6, 2022
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancerYuanwang Pan, Yuan Hao, Han Han, et al.
Cancer Research|August 12, 2021
Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaAngeliki Karatza, Maayan Pour, Jaylen M Powell, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Pageof 3